CH564035A5 - - Google Patents

Info

Publication number
CH564035A5
CH564035A5 CH77569A CH77569A CH564035A5 CH 564035 A5 CH564035 A5 CH 564035A5 CH 77569 A CH77569 A CH 77569A CH 77569 A CH77569 A CH 77569A CH 564035 A5 CH564035 A5 CH 564035A5
Authority
CH
Switzerland
Application number
CH77569A
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR837273A priority Critical patent/FR567M/fr
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of CH564035A5 publication Critical patent/CH564035A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B7/00—Mountings, adjusting means, or light-tight connections, for optical elements
    • G02B7/20—Light-tight connections for movable optical elements
    • G02B7/22—Extensible connections, e.g. bellows

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Moulds For Moulding Plastics Or The Like (AREA)
CH77569A 1959-11-24 1969-01-20 CH564035A5 (xx)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837273A FR567M (xx) 1959-11-24 1960-08-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3100/68A GB1253831A (en) 1968-01-19 1968-01-19 9alpha,21-DIHALOPREGNANE COMPOUNDS

Publications (1)

Publication Number Publication Date
CH564035A5 true CH564035A5 (xx) 1975-07-15

Family

ID=9751941

Family Applications (2)

Application Number Title Priority Date Filing Date
CH77569A CH564035A5 (xx) 1959-11-24 1969-01-20
CH116472A CH564563A5 (xx) 1968-01-19 1969-01-20

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH116472A CH564563A5 (xx) 1968-01-19 1969-01-20

Country Status (14)

Country Link
US (1) US3721687A (xx)
BE (1) BE727109A (xx)
BR (1) BR6905681D0 (xx)
CA (1) CA952900A (xx)
CH (2) CH564035A5 (xx)
DK (1) DK126500B (xx)
ES (1) ES362679A1 (xx)
FR (1) FR2000443A1 (xx)
GB (1) GB1253831A (xx)
IE (1) IE33204B1 (xx)
IL (1) IL31447A (xx)
NL (1) NL6900795A (xx)
NO (1) NO132100C (xx)
SE (1) SE350035B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4154748A (en) * 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
IT1194178B (it) * 1983-03-29 1988-09-14 Ricerche Steroidi Sirs Spa Soc Processo per la preparazione di 17-esteri di clobetasolo e composti ottenuti
ES2078175B1 (es) * 1993-12-31 1996-10-16 Cusi Lab Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
US20090304603A1 (en) * 2001-06-15 2009-12-10 Cuticeuticals, Inc. Topical steroid spray with botanic seed oils
US20040022741A1 (en) * 2001-06-15 2004-02-05 Crutchfield Charles E. Topical steroid spray
WO2005021515A2 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
RU2008119322A (ru) * 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Композиции ингибиторов фосфодиэстеразы iv типа
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
CA2664247A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
EP2124944B1 (en) * 2007-03-14 2012-02-15 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors
WO2008111009A1 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
US8796248B2 (en) 2007-10-05 2014-08-05 Nektar Therapeutics Oligomer-corticosteroid conjugates
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN101812107B (zh) * 2010-04-20 2013-05-01 浙江仙居仙乐药业有限公司 一种合成丙酸氯倍他索的方法
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same

Also Published As

Publication number Publication date
DK126500B (da) 1973-07-23
NO132100C (xx) 1975-09-17
GB1253831A (en) 1971-11-17
US3721687A (en) 1973-03-20
SE350035B (xx) 1972-10-16
DE1902340B2 (de) 1977-06-08
IL31447A (en) 1973-11-28
IE33204L (en) 1969-07-19
IE33204B1 (en) 1974-04-17
DE1902340A1 (de) 1969-09-11
IL31447A0 (en) 1969-03-27
FR2000443A1 (xx) 1969-09-05
CH564563A5 (xx) 1975-07-31
BR6905681D0 (pt) 1973-02-08
CA952900A (en) 1974-08-13
NO132100B (xx) 1975-06-09
BE727109A (xx) 1969-07-22
NL6900795A (xx) 1969-07-22
ES362679A1 (es) 1971-02-01

Similar Documents

Publication Publication Date Title
AU428130B2 (xx)
NO132100C (xx)
AU5184069A (xx)
AU6168869A (xx)
AU6171569A (xx)
AU429879B2 (xx)
AU4304568A (xx)
AU2581067A (xx)
AU4811568A (xx)
AU4744468A (xx)
AU479894A (xx)
BE727527A (xx)
AU463027A (xx)
AU4558658A (xx)
AU4503667A (xx)
AU5758767A (xx)
BE709320A (xx)
AU4464266A (xx)
BE728650A (xx)
BE728386A (xx)
BE728334A (xx)
BE727980A (xx)
BE727950A (xx)
BE727828A (xx)
AU479393A (xx)

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: GLAXO OPERATIONS UK LIMITED

PL Patent ceased